DK0458589T3 - Behandling af okulær hypertension med en okulær synergistisk kombination - Google Patents

Behandling af okulær hypertension med en okulær synergistisk kombination

Info

Publication number
DK0458589T3
DK0458589T3 DK91304575.3T DK91304575T DK0458589T3 DK 0458589 T3 DK0458589 T3 DK 0458589T3 DK 91304575 T DK91304575 T DK 91304575T DK 0458589 T3 DK0458589 T3 DK 0458589T3
Authority
DK
Denmark
Prior art keywords
ocular
treatment
synergistic combination
hypertension
ocular hypertension
Prior art date
Application number
DK91304575.3T
Other languages
Danish (da)
English (en)
Inventor
Ryuji Ueno
Original Assignee
R Tech Ueno Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=15092428&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0458589(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by R Tech Ueno Ltd filed Critical R Tech Ueno Ltd
Application granted granted Critical
Publication of DK0458589T3 publication Critical patent/DK0458589T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
DK91304575.3T 1990-05-22 1991-05-21 Behandling af okulær hypertension med en okulær synergistisk kombination DK0458589T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP13291290 1990-05-22

Publications (1)

Publication Number Publication Date
DK0458589T3 true DK0458589T3 (da) 1995-04-03

Family

ID=15092428

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91304575.3T DK0458589T3 (da) 1990-05-22 1991-05-21 Behandling af okulær hypertension med en okulær synergistisk kombination

Country Status (9)

Country Link
US (1) US5397797A (de)
EP (1) EP0458589B1 (de)
JP (1) JP2511587B2 (de)
KR (1) KR960010437B1 (de)
AT (1) ATE117208T1 (de)
CA (1) CA2042934C (de)
DE (1) DE69106777T2 (de)
DK (1) DK0458589T3 (de)
ES (1) ES2069823T3 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5641794A (en) * 1991-03-28 1997-06-24 Eli Lilly Company 6-heterocyclic-4-amino-1,2,2a,3,4,5-hexahydrobenz[cd]indoles
CA2146127C (en) * 1992-10-13 2000-06-13 Louis Desantis, Jr. Combinations of prostaglandins and clonidine derivatives for the treatment of glaucoma
US5710165A (en) * 1994-07-06 1998-01-20 Synthelabo Use of polyamine antagonists for the treatment of glaucoma
AU1138097A (en) * 1995-12-22 1997-07-17 Alcon Laboratories, Inc. Combinations of prostaglandins and miotics for lowering intraocular pressure
EP0949688A1 (de) * 1998-03-31 1999-10-13 Phototronics Solartechnik GmbH Dünnschichtsolarzelle, Verfahren zu deren Herstellung sowie Vorrichtung zur Durchführung des Verfahrens
CA2433346A1 (en) * 2000-12-29 2002-07-11 John J. Egan Method for treating glaucoma ib
US20020133009A1 (en) * 2001-03-13 2002-09-19 Lambrou George N. Method for opening potassium channels
US20040007269A1 (en) * 2002-07-12 2004-01-15 Larsen Todd W. Inline pressure reducing regulator
US20040225014A1 (en) * 2003-02-14 2004-11-11 Sucampo Ag Method for treating ocular hypertension and glaucoma
TWI348386B (en) * 2003-08-12 2011-09-11 R Tech Ueno Ltd Composition and method for promoting hair growth
US7757710B2 (en) * 2006-06-19 2010-07-20 Tescom Corporation High-pressure regulator

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4599353A (en) * 1982-05-03 1986-07-08 The Trustees Of Columbia University In The City Of New York Use of eicosanoids and their derivatives for treatment of ocular hypertension and glaucoma
EP0242580B1 (de) * 1986-03-13 1993-04-28 The Trustees Of Columbia University In The City Of New York Verwendung von A-, B- und C-Prostaglandinen und deren Derivaten zur Behandlung von Augen-Hypertension und Glaukom
US4824857A (en) * 1986-05-16 1989-04-25 Yasumasa Goh Use of prostaglandin D2 -active substances
ES2042625T5 (es) * 1987-04-03 2000-07-16 Univ Columbia Uso de una prostaglandina en combinacion con un agente bloqueante adrenergico para la reduccion de presion intraocular.
ES2052735T3 (es) * 1987-09-18 1994-07-16 R Tech Ueno Ltd Un metodo para producir un agente hipotensor ocular.
EP0580268B1 (de) * 1988-10-01 1998-01-14 R-Tech Ueno Ltd. Oculare hypotensive Mittel

Also Published As

Publication number Publication date
DE69106777D1 (de) 1995-03-02
ATE117208T1 (de) 1995-02-15
DE69106777T2 (de) 1995-05-18
KR910019623A (ko) 1991-12-19
CA2042934A1 (en) 1991-11-23
EP0458589A1 (de) 1991-11-27
CA2042934C (en) 2002-04-23
JPH04253912A (ja) 1992-09-09
KR960010437B1 (ko) 1996-08-01
ES2069823T3 (es) 1995-05-16
JP2511587B2 (ja) 1996-06-26
US5397797A (en) 1995-03-14
EP0458589B1 (de) 1995-01-18

Similar Documents

Publication Publication Date Title
DK0453127T3 (da) Behandling af katarakt med 15-keto-prostaglandinforbindelser
ES2071227T3 (es) Composicion para gotas para los ojos.
ATE179173T1 (de) 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy 1,3-propandiol-derivate
ATE133663T1 (de) Antiglancoma-zusammensetzungen enthaltend 3- arylcarbonyl-1-aminoalkyl-1h-indol
DK0458589T3 (da) Behandling af okulær hypertension med en okulær synergistisk kombination
DE69130586D1 (de) Behandlung von Pankreaskrankheit mit 15-keto-Prostaglandin E-Derivaten
DK0458590T3 (da) Behandling af okulær hypertension med en synergistisk konbination
DE58902899D1 (de) 2',3'-dideoxypurinnucleosid/purinnucleosid-phosphorylase-inhibitor kombinationstherapie und zusammensetzungen dafuer.
DK0424156T3 (da) Behandling af hepatobiliær sygdom med 15-ketoprostaglandinforbindelser
ATE133337T1 (de) Behandlung des glaukoms mit synergistischer kombination
DK0458587T3 (da) Behandling af okulær hypertension med en synergistisk kombination til ophthalmisk anvendelse
DK0430551T3 (da) Behandling af hjertedysfunktion med 15-keto-prostaglandinforbindelser
DE69023459T2 (de) Behandlung von pulmonarer Disfunktion mit 15-Keto-prostaglandin-Derivaten.
DK0458537T3 (da) Anvendelse af en terapeutisk forbindelse til behandling af bronkitis
DK0469782T3 (da) Behandling af katarakt med prostacyclinforbindelser
DK435089D0 (da) Anvendelse af zofenopril til behandling af rheumatoid arthritis
DK0661058T3 (da) Anvendelse af bradykininantagonister til behandling af virussygdomme